Levin Capital Strategies L.P. Increases Holdings in Alpha Tau Medical Ltd. (NASDAQ:DRTS)

Levin Capital Strategies L.P. increased its holdings in shares of Alpha Tau Medical Ltd. (NASDAQ:DRTS) by 2.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 314,514 shares of the company’s stock after purchasing an additional 7,189 shares during the period. Levin Capital Strategies L.P. owned 0.45% of Alpha Tau Medical worth $975,000 as of its most recent filing with the Securities and Exchange Commission.

Alpha Tau Medical Trading Up 9.0 %

Shares of Alpha Tau Medical stock opened at $3.02 on Friday. The company has a fifty day moving average price of $3.34 and a 200 day moving average price of $2.75. Alpha Tau Medical Ltd. has a twelve month low of $1.75 and a twelve month high of $4.39. The stock has a market cap of $211.17 million, a price-to-earnings ratio of -7.02 and a beta of 0.83.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and set a $9.00 price target on shares of Alpha Tau Medical in a research report on Friday, November 22nd.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.